Clinical Trial Update: An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating Exenatide and Rosiglitazone in adults with Type 2 diabetes, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)
• BYETTA (Exenatide)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2009-08-28